Qiongzhu R. Dong
12 Urumqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
Tumor cell-derived HSP47 promotes pancreatic Cancer metastasis via Homotrimeric collagen-mediated M2 macrophage polarization.
Journal: Cellular signalling
Published: February 26, 2026
IGF2BP1-Mediated m6A Modification Stabilizes HMGA2 mRNA to Promote Intrahepatic Cholangiocarcinoma Progression.
Journal: Cellular and molecular gastroenterology and hepatology
Published: November 10, 2025
Mitophagy in pancreatic cancer: mechanistic insights and implications for novel therapeutic strategies.
Journal: Cell death discovery
Published: September 21, 2025
Liver ischemia-reperfusion promotes tumor metastasis via neutrophil-endothelial interactions: targeting ICAM1 to prevent metastatic recurrence.
Journal: Journal of translational medicine
Published: September 02, 2025
DNMT2-m5C-ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation-Mediated Notch Pathway.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 21, 2025
Spatial Transcriptomics and snRNA-seq Expose CAF Niches Orchestrating Dual Stromal-Immune Barriers in Hepatocellular Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 01, 2025
Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 31, 2025
WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: October 13, 2024
Correction for: The association between KLF4 as a tumor suppressor and the prognosis of hepatocellular carcinoma after curative resection.
Journal: Aging
Published: September 26, 2024
LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation.
Journal: Cancer letters
Published: September 22, 2024
Last Updated: 09/26/2026